Helping kids with severe obesity reduce heart risks
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial tests whether semaglutide can lower heart disease risks in children with extreme obesity. It aims to improve weight and heart health over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be seen at the UK Pediatric High BMI Clinic.
- You must have Class 2 or 3 obesity (severe obesity).
- You must qualify for semaglutide treatment for weight loss.
- You cannot be taking any other weight-loss or blood pressure medicines.
- You cannot have certain health problems like kidney or liver disease.
- You cannot be pregnant, or have a history of a rare thyroid cancer in your family.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether weight loss from a medication can improve how you feel, move, and how well your heart works. It's for people who have both obesity and heart failure with reduced pumping strength.
This study tests whether semaglutide (a weight-loss medication) works differently in people with varying degrees of insulin resistance (how well your body uses sugar). If you are obese without diabetes, you may be able to join.
This study compares different diets to see how they affect “arterial stiffness” (how hard the blood vessels are) in people with obesity who are starting semaglutide for weight management. It may help find a diet approach that improves heart and blood-vessel health while you use semaglutide.
This study tests whether semaglutide (a once-weekly injection that helps with weight loss) can help teenagers with autism who are obese. It will compare their results to similar teens who did not take the drug to see if it is safe and effective.
This trial studies whether semaglutide (a once-weekly injection) helps adolescents with a specific genetic form of obesity lose weight. It is for teens who are already being prescribed semaglutide as part of their regular care.
This trial studies how the body adapts to weight loss in teens with obesity. You will either get a behavioral lifestyle program alone or with a weight loss medication called semaglutide.
Hear when a new Obese Adolescents trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.